HAART Annuloplasty Device Valve Repair Registry

ClinicalTrials.gov ID: NCT04035356

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04035356. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Performance of Aortic Valve Repair Using the HAART Aortic Annuloplasty Devices - A Registry Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Multicenter US registry study to assess procedure success and long-term (10-year) performance of the HAART 200 and HAART 300 Aortic Annuloplasty Devices when used during aortic valve repair in a routine cardiovascular practice setting.

Study identification

NCT ID: NCT04035356
Recruitment status: Terminated
Study type: Observational
Phase: Not listed
Lead sponsor: Biostable Science & Engineering; Industry
Enrollment: 183 participants

Conditions and interventions

Conditions

Interventions

Aortic valve repair Device

Device

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 22, 2020 (Actual)
Primary completion: Jul 25, 2024 (Actual)
Completion: Jul 25, 2024 (Actual)
Last update posted: Aug 9, 2024

2020 – 2024

United States locations

U.S. sites: 5
U.S. states: 5
U.S. cities: 5

Facility	City	State	ZIP	Site status
Franciscan Health Indianapolis	Indianapolis	Indiana	46237	—
University of Michigan Medical Center	Ann Arbor	Michigan	48109	—
Missouri Baptist Medical Center	St Louis	Missouri	63131	—
Duke University	Durham	North Carolina	27705	—
West Virginia University Heart & Vascular institute	Morgantown	West Virginia	26506	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04035356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 9, 2024 · Synced Nov 15, 2026